| Literature DB >> 24866155 |
Esther F Gijsbers1, Ad C van Nuenen1, Alba Torrents de la Peňa1, Emma J Bowles2, Guillaume B Stewart-Jones2, Hanneke Schuitemaker3, Neeltje A Kootstra1.
Abstract
Mother-to-child HIV-1 transmission pairs represent a good opportunity to study the dynamics of CTL escape and reversion after transmission in the light of shared and non-shared HLA-alleles. Mothers share half of their HLA alleles with their children, while the other half is inherited from the father and is generally discordant between mother and child. This implies that HIV-1 transmitted from mother to child enters a host environment to which it has already partially adapted. Here, we studied viral evolution and the dynamics of CTL escape mutations and reversion of these mutations after transmission in the context of shared and non-shared HLA alleles in viral variants obtained from five mother-to-child transmission pairs. Only limited HIV-1 evolution was observed in the children after mother-to-child transmission. Viral evolution was mainly driven by forward mutations located inside CTL epitopes restricted by HLA alleles inherited from the father, which may be indicative of CTL pressure.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24866155 PMCID: PMC5381489 DOI: 10.1038/srep05079
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Characteristics of mother-child transmission pairs
| Number of sequences analyzed | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Mother-child couple | Date of birth | Time point after delivery/birth (months) | Nef | Gag | Env | HLA alleles | ||||
| 102 | Mother | 18 Feb 1961 | −7 | 9 | 11 | 11 | A*0201 | A*2402 | B*3701 | B*1801 |
| −0.5 | 18 | 17 | 18 | |||||||
| Child | 31 Jan 1989 | +2.5 | 9 | 8 | 10 | A*0201 | A*0206 | B*3701 | B*0702 | |
| 114 | Mother | 07 Oct 1960 | −2 | 1 | 1 | 1 | A*2301/2317 | A*6601 | B*3501/3542 | B*5101 |
| +31.5 | 3 | 2 | 3 | |||||||
| Child1 | 03 Apr 1990 | +10 | 9 | 15 | 16 | A*2301/2317 | A*2301/2317 | B*3501/3542 | B*4501 | |
| +25.5 | 8 | 11 | 10 | |||||||
| 127 | Mother | 07 Oct 1969 | −7 | 1 | 3 | 4 | A*7401 | A*2301 | B*1516 | B*1801 |
| −0.5 | 2 | NA | 11 | |||||||
| Child | 24 Oct 1991 | +10.5 | 5 | 9 | 4 | A*7401 | A*0101 | B*1516 | B*4403 | |
| 133 | Mother | 14 Apr 1961 | +6 | 7 | 6 | 4 | A*0101 | A*0301 | B*4402 | B*0702/0761 |
| Child | 31 July 1991 | 02 | 2 | 3 | 2 | A*0101 | A*0201 | B*4402 | B*2705/2713 | |
| +9.5 | 5 | 6 | 4 | |||||||
| 137 | Mother | 07 Nov 1963 | −1.5 | 3 | 3 | 3 | A*0201 | A*0201 | B*0702 | B*4402 |
| +9.5 | 14 | 19 | 19 | |||||||
| Child | 01 Oct 1991 | +12.5 | 5 | 6 | 3 | A*0201 | A*0101 | B*0702 | B*0801 | |
NA: not available. 1: child infected during pregnancy. 2: cord blood sample.
Genetic divergence and dN/dS ratios of sequences obtained from mother and child, or from two successive time points of the child
| Divergence | dN/dS | |||||||
|---|---|---|---|---|---|---|---|---|
| Mother-child couple | Time point after delivery/birth (months) | Gene | Mean | SD | 95% CI1 | Mean | SD | 95% CI1 |
| 102 | Mother −0.5Child +2.5 | Nef | 1.42 | 0.38 | 0.66–2.18 | 0.30 | 0.21 | −0.12–0.71 |
| Gag | 1.36 | 0.24 | 0.88–1.84 | 0.14 | 0.11 | −0.08–0.36 | ||
| Env | 2.67 | 0.2 | 2.27–3.07 | 0.52 | 0.10 | 0.31–0.73 | ||
| V1V2 | 0.70 | 0.33 | 0.04–1.37 | |||||
| V3 | 0.30 | 0.37 | −0.45–1.04 | |||||
| V4 | 2.35 | 1.79 | −1.23–5.94 | |||||
| V5 | 1.00 | 0.17 | 0.66–1.34 | |||||
| 114 | Child +10 | Nef | 1.96 | 0.39 | 1.18–2.74 | 0.73 | 0.53 | −0.33–1.80 |
| Child +25.5 | Gag | 0.59 | 0.11 | 0.37–0.81 | 0.62 | 0.65 | −0.68–1.91 | |
| Env | 1.77 | 0.14 | 1.49–2.05 | 0.51 | 0.14 | 0.24–0.79 | ||
| V1V2 | 0.71 | 0.43 | −0.12–1.57 | |||||
| V3 | 0.93 | 0.20 | 0.53–1.34 | |||||
| V4 | 0.71 | 0.39 | −0.06–1.49 | |||||
| V5 | 0.82 | 0.86 | −0.90–2.55 | |||||
| 127 | Mother −0.5 | Nef | 2.63 | 0.47 | 1.69–3.57 | 1.98 | 1.62 | −1.27–5.22 |
| Child +10.5 | Gag2 | 0.99 | 0.23 | 0.53–1.45 | 0.22 | 0.08 | 0.06–0.39 | |
| Env | 2.10 | 0.17 | 1.76–2.44 | 0.73 | 0.21 | 0.31–1.14 | ||
| V1V2 | 0.57 | 0.57 | −0.58–1.71 | |||||
| V3 | 0.86 | 0.24 | 0.37–1.35 | |||||
| V4 | 2.00 | 1.09 | −0.12–4.18 | |||||
| V5 | 0.84 | 0.27 | 0.30–1.38 | |||||
| 133 | Child 03Child +9.5 | Nef | 1.86 | 0.42 | 1.02–2.70 | 1.39 | 0.81 | −0.22–3.01 |
| Gag | 1.76 | 0.33 | 1.10–2.42 | 0.30 | 0.08 | 0.15–0.45 | ||
| Env | 3.92 | 0.34 | 3.24–4.60 | 0.66 | 0.06 | 0.54–0.79 | ||
| V1V2 | 1.33 | 0.06 | 1.21–1.45 | |||||
| V3 | 0.62 | 0.42 | −0.22–1.46 | |||||
| V4 | 1.01 | 0.24 | 0.53–1.50 | |||||
| V5 | 0.85 | 0.44 | −0.04–1.74 | |||||
| 137 | Mother −1.5Child +12.5 | Nef | 1.41 | 0.35 | 0.71–2.11 | 0.63 | 0.52 | −0.42–1.68 |
| Gag | 1.11 | 0.22 | 0.67–1.55 | 0.07 | 0.03 | 0.00–0.13 | ||
| Env | 2.35 | 0.23 | 1.89–2.81 | 0.46 | 0.40 | −0.34–1.26 | ||
| V1V2 | 1.60 | 0.47 | 0.67–2.53 | |||||
| V3 | 0.36 | 0.16 | 0.04–0.68 | |||||
| V4 | 0.76 | 0.25 | 0.26–1.25 | |||||
| V5 | 0.76 | 0.36 | 0.04–1.48 | |||||
1: 95% confidence interval. 2: sequences from 7 months before delivery were used.
3: cord blood sample. NA: not available.
Figure 1Dynamics of CTL escape mutations after HIV-1 transmission from mother to child.
Reversion of transmitted mutations (white) and forward mutations (grey) in HIV-1 variants obtained from the children. Mutations located at anchor residues of predicted CTL epitopes are depicted in black, both for reversions and forward mutations. (a). Reversion of transmitted mutations located in predicted CTL epitopes restricted by non-shared maternal HLA alleles. (b). Reversion of transmitted mutations and forward mutations located in predicted CTL epitopes restricted by HLA alleles that are shared between mother and child. (c). Reversion of transmitted mutations and forward mutations located in predicted CTL epitopes restricted by paternal HLA alleles from the child. (d). Reversion of transmitted mutations and forward mutations located outside of predicted CTL epitopes.